Regulatory Affairs · Merchant Export · Market Entry
Healglobal Tradelink helps overseas buyers and Indian manufacturers move pharmaceutical products across borders — backed by deep regulatory expertise and PIC/s, WHO-GMP, and EU-GMP approved manufacturing partners.
Certified Partners
PIC/s · WHO-GMP · EU-GMP
End-to-End Ownership
Regulatory to supply
4 Key Regions
Africa · SE Asia · CIS · MENA
Scientific Leadership
PhD-led regulatory strategy
What we do
End-to-end support for pharmaceutical product registration in emerging markets. CTD and ACTD dossier preparation, regulatory strategy, Q1/Q2/Q3 analysis, biowaiver positioning, and response handling.
Explore RA servicesSourcing quality pharmaceutical formulations from India for overseas buyers. All manufacturing partners hold PIC/s, WHO-GMP, or EU-GMP certification. Coverage across eight therapeutic categories.
See our portfolioFor Indian manufacturers entering new export markets — regulatory pathway selection, dossier preparation, market entry strategy, and partnership facilitation.
Partner with usMost merchant exporters can move product. Few can also navigate the regulatory complexity of getting that product registered in your market. Healglobal does both, under one team.
Dr. Gauri Chandrethiya, our Director and CEO, brings a PhD in pharmaceutical sciences and deep technical expertise in formulations, bioequivalence, and drug delivery systems. This shapes every product decision.
From identifying a market opportunity to selecting the right manufacturing partner, preparing the dossier, handling regulatory queries, and supplying the registered product — one team, one accountability.
Every product is sourced from a manufacturing partner holding PIC/s, WHO-GMP, or EU-GMP certification. No exceptions.
Recent and active engagements across our three service pillars.
Five Healglobal-branded antiretroviral products registered in Myanmar, covering first-line and combination ART regimens.
Supported an Indian manufacturer in preparing and submitting an ophthalmic dossier to NAFDAC, including Q1/Q2 sameness analysis and biowaiver strategy.
Coordinated multi-product supply for a regional distributor's tender, covering oral antibiotics, IV fluids, and hospital injectables.
Where we work
5+
Southeast Asia
Myanmar · Philippines · Vietnam · Cambodia · Indonesia
4+
Sub-Saharan Africa
Nigeria · Tanzania · Côte d'Ivoire · Senegal
3+
CIS & Central Asia
Belarus · Uzbekistan · Kazakhstan
2+
Middle East & N. Africa
UAE · Algeria
From antivirals and hospital injectables to oncology, ophthalmics, antimalarials, and chronic care. Each formulation sourced from PIC/s, WHO-GMP, or EU-GMP approved manufacturing partners.
We respond within one business day.
Where we're headed
Active markets worldwide
Active SKUs across therapeutic areas
Sourcing from GMP-certified partners
Let's talk
Tell us what you're working on. We'll respond within one business day.
Talk to our regulatory team
